SCHEMBL19377071

SCHEMBL19377071

CC(NC(=O)Nc1ccc(S(=O)(=O)Cc2ccc3c(c2)CNC3)cc1)c1cccc(Cl)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MLNR O43193 4/20 0.39
▸ GHSR Q92847 1/20 0.36
▸ USP28 Q96RU2 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ PCTP Q9UKL6 1/20 0.35
▸ STARD10 Q9Y365 1/20 0.35
▸ IDH1 O75874 1/20 0.35
▸ ITGB1 P05556 2/20 0.35
▸ ITGA4 P13612 2/20 0.35
▸ CCR3 P51677 1/20 0.35
▸ FAAH O00519 1/20 0.35
▸ MGLL Q99685 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377070 1.00 MLNR (0.39) MLNRGHSRUSP28DRD2DRD3
SCHEMBL19377369 0.93 MLNR (0.46) MLNRDRD2DRD3HTR6
SCHEMBL19377366 0.93 MLNR (0.46) MLNRDRD2DRD3HTR6
SCHEMBL19377656 0.93 MLNR (0.46) MLNRUSP28DRD2DRD3HTR6
SCHEMBL19377658 0.93 MLNR (0.46) MLNRUSP28DRD2DRD3HTR6
SCHEMBL19377448 0.93 MLNR (0.40) MLNRUSP28DRD2DRD3HTR6
SCHEMBL19398854 0.89 NPC1 (0.42) MLNRMEN1MAPTKMT2AALDH1A1
SCHEMBL24799953 0.89 GHSR (0.35) MLNRGHSRPCTPSTARD10IDH1
SCHEMBL19377143 0.89 GHSR (0.35) MLNRGHSRPCTPSTARD10IDH1
SCHEMBL19377342 0.88 MLNR (0.36) MLNRGHSRPCTPSTARD10IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR MLNR 24/4885GHSR 2/4885USP28 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback